Comments Regarding Control of Nitrosamine Impurities in Human Drugs Share page: Docket Number: FDA-2020-D-1530 Download Document Issues: OTC Medicines Other Issues Ingredient Safety Quality Related Posts Press Releases and Statements CHPA Applauds Bipartisan Bill to Streamline Access to Next-Generation Sunscreens in the U.S. Jun 4, 2025 2025 Mid-Year Impact Report Jun 20, 2025 Comments Comments Regarding Amending OTC Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Human Use May 7, 2025